Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|April 21, 2012
Neuronal caspase 2 activity and function requires RAIDD, but not PIDDElena M Ribe, Ying Y Jean, Rebecca L Goldstein, et al.
The Journal of Clinical Investigation|November 4, 2015
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphomaRebecca L Goldstein, Shao Ning Yang, Tony Taldone, et al.
Blood|August 15, 2013
Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignanciesUtthara Nayar, Pin Lu, Rebecca L Goldstein, et al.
Blood Advances|September 4, 2020
AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeysRebecca L Goldstein, Ana Goyos, Chi-Ming Li, et al.
Blood Advances|February 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Blood Advances|December 1, 2025
FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell ExhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Blood|November 26, 2015
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomasBiljana Culjkovic-Kraljacic, Tharu M Fernando, Rossella Marullo, et al.
Cancer Cell|August 10, 2016
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and LymphomagenesisWendy Béguelin, Matt Teater, Micah D Gearhart, et al.
The Journal of Clinical Investigation|August 3, 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphomaMariano G Cardenas, Wenbo Yu, Wendy Beguelin, et al.
Molecular Cancer Therapeutics|June 11, 2020
Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid LeukemiaBettina Brauchle, Rebecca L Goldstein, Christine M Karbowski, et al.
Pageof 1